Moderna’s stock jumps after biotech raises sales outlook
The company lifted its revenue outlook for the year, saying it now expects revenue to grow as much as 25% in 2026.
Original Source
Read the full article at Marketwatch →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.